The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127056931 12705693 1 I 20160818 20160901 20160901 EXP IT-CIPLA LTD.-2016IT17680 CIPLA MIKULSKA M, TARAMASSO L, GIACOBBE DR, CALIGIURI P, BRUZZONE B, DI BIAGIO A ET AL. CASE REPORT: MANAGEMENT AND HBV SEQUENCING IN A PATIENT CO-INFECTED WITH HBV AND HIV FAILING TENOFOVIR. JOURNAL OF MEDICAL VIROLOGY. 2012;84:1340 TO 1343 0.00 Y 0.00000 20160901 OT IT IT

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127056931 12705693 1 PS LAMIVUDINE. LAMIVUDINE 1 Unknown UNK U U 0
127056931 12705693 2 SS LAMIVUDINE. LAMIVUDINE 1 U U 0
127056931 12705693 3 SS Tenofovir TENOFOVIR 1 Unknown UNK U U 0
127056931 12705693 4 SS Tenofovir TENOFOVIR 1 Unknown UNK U U 0
127056931 12705693 5 SS Tenofovir TENOFOVIR 1 Unknown 245 MG, DAILY U U 0 245 MG
127056931 12705693 6 SS Emtricitabine EMTRICITABINE 1 Unknown 200 MG, DAILY U U 0 200 MG
127056931 12705693 7 SS Emtricitabine EMTRICITABINE 1 U U 0
127056931 12705693 8 SS RITONAVIR. RITONAVIR 1 Unknown 200 MG, DAILY U U 0 200 MG
127056931 12705693 9 SS RITONAVIR. RITONAVIR 1 U U 0
127056931 12705693 10 SS DARUNAVIR DARUNAVIR 1 Unknown 1200 MG, DAILY U U 0 1200 MG
127056931 12705693 11 SS DARUNAVIR DARUNAVIR 1 U U 0
127056931 12705693 12 SS RALTEGRAVIR. RALTEGRAVIR 1 Unknown 800 MG, DAILY U U 0 800 MG
127056931 12705693 13 SS RALTEGRAVIR. RALTEGRAVIR 1 U U 0
127056931 12705693 14 SS Enfuvirtide ENFUVIRTIDE 1 Unknown 180 MG, DAILY U U 0 180 MG
127056931 12705693 15 SS Enfuvirtide ENFUVIRTIDE 1 U U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127056931 12705693 1 Hepatitis B
127056931 12705693 2 HIV infection
127056931 12705693 3 Hepatitis B
127056931 12705693 4 HIV infection
127056931 12705693 6 Hepatitis B
127056931 12705693 7 HIV infection
127056931 12705693 8 Hepatitis B
127056931 12705693 9 HIV infection
127056931 12705693 10 Hepatitis B
127056931 12705693 11 HIV infection
127056931 12705693 12 Hepatitis B
127056931 12705693 13 HIV infection
127056931 12705693 14 Hepatitis B
127056931 12705693 15 HIV infection

Outcome of event

Event ID CASEID OUTC COD
127056931 12705693 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
127056931 12705693 Abdominal lymphadenopathy
127056931 12705693 Cachexia
127056931 12705693 Disease recurrence
127056931 12705693 Drug resistance
127056931 12705693 Gastrointestinal disorder
127056931 12705693 Immunodeficiency
127056931 12705693 Mycobacterium avium complex infection
127056931 12705693 Treatment failure
127056931 12705693 Treatment noncompliance
127056931 12705693 Virologic failure

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
127056931 12705693 3 200409 200604 0
127056931 12705693 4 200409 200604 0
127056931 12705693 5 200807 0
127056931 12705693 6 200807 0
127056931 12705693 8 200807 0
127056931 12705693 10 200807 0
127056931 12705693 12 200807 0
127056931 12705693 14 200807 0